BioSpace News Archive

The proposal, which is similar to a prescription drug plan put forth by House Speaker Nancy Pelosi last month, also aims to boost new federal investments in drug development and manufacturing.

A new computer kidney developed at the University of Waterloo could tell researchers more about the impacts of medicines taken by people who don’t drink enough water.

Vascular Graft Solutions reports the presentation of Clinical data from two prospective trials of the VEST external stent for vein grafts during CABG which was presented at the 2019 European Cardio-Thoracic Surgery (EACTS) annual meeting (3-5 October, Lisbon, Portugal)

Equity research is published in the framework of Frost’s Independent Equity Research Program.

Stealth BioTherapeutics (NASDAQ: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction, announced the presentation of pre-clinical data for its lead pipeline compound, SBT-272, at the 18th Annual Northeast Amyotrophic Lateral Sclerosis Consortium in Clearwater Beach, Fla.

Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with cancer, announces the publication of a peer-reviewed journal article featuring analytical validation results demonstrating the high sensitivity of the Company’s Target Selector™ testing

Advaxis, Inc. (Nasdaq: ADXS), a clinical-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, today announced updated median overall survival data from its Phase 1/2 KEYNOTE-046 study in metastatic, castration-resistant prostate cancer (mCRPC).

Abiomed (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, announces the 1,000th patient has been treated with the Impella heart pump in Japan.

MedX Health Corp. (“MedX” or the “Company”) (TSX-V: MDX) experienced strong interest for its SIAscopy on DermSecureTM platform from physicians and dermatologists in Brazil during the recent 74th Congress of the Brazilian Society of Dermatology held in Rio de Janeiro in September 2019

Veracyte, Inc. (Nasdaq: VCYT) today announced that preliminary clinical data for the company’s noninvasive nasal swab test – the first of its kind – for early detection of lung cancer will be presented at the annual meeting of the American College of Chest Physicians® (CHEST), being held October 18-23 in New Orleans.